+86 400-682-2521 | order.cn@acrobiosystems.com 注册
登录 | 注册    关注公众号 |  
微信公众号
ACRO百普赛斯_logo Recombinant Proteins iso9001 ISO13485 CNAS
热门搜索：TL1A Hot|GMP细胞因子Hot|FcRn Binding Kit (TR-FRET)New|ADC定点偶联试剂盒
ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9
搜索
 > 【P-Selectin】

P-Selectin信息

英文名称：P-selectin
中文名称：P-选择素
靶点别称：Platelet Activation Dependent Granule-External Membrane Protein，Granule Membrane Protein 140kDa，PADGEM，GRMP，Selectin P (Granule Membrane Protein 140kD， Antigen CD62)，Platelet Alpha-Granule Membrane Protein，Granulocyte Membrane Protein，CD62P Antigen，Antigen CD62，P-Selectin，GMP140，CD62P，CD62，PSEL，LECAM3，CD62 antigen-like family member P，GMRP，GMP-140，Granule membrane protein 140，SELP，Selectin P，Selectin P (Granule Membrane Protein 140kDa， Antigen CD62)，Leukocyte-Endothelial Cell Adhesion Molecule 3
上市药物数量：1
临床药物数量：1
最高研发阶段：批准上市

P-Selectin产品列表

筛选结果
产品库
物种
标签
属性
标记
货号 物种 产品描述 蛋白结构 纯度 活性
SEP-H5255
Human		 Human P-Selectin / CD62P Protein, Fc Tag
SEP-H52E4
Human		 Human P-Selectin / CD62P Protein, His Tag
ACRO质量管理体系
 
评论(0)
 

P-Selectin分子别名

P-Selectin,CD62P,SELP,GMP-140

P-Selectin分子背景

P-selectin (SELP) is also known as CD62 antigen-like family member P, granule membrane protein 140 (GMP-140), leukocyte-endothelial cell adhesion molecule 3 (LECAM3) and platelet activation dependent granule-external membrane protein (PADGEM). SELP functions as a cell adhesion molecule (CAM) on the surfaces of activated endothelial cells, which line the inner surface of blood vessels, and activated platelets. In unactivated endothelial cells, it is stored in granules called Weibel-Palade bodies. In unactivated platelets SELP is stored in α-granules. The primary ligand for SELP is P-selectin glycoprotein ligand-1 (PSGL-1) which is expressed on almost all leukocytes, although P-selectin also binds to heparan sulfate and fucoidan. Furthermore, SELP has a functional role in metastasis of tumor similar to E-selectin, which can help cancer cells invade into bloodstream for metastasis and provided locally with multiple growth factors respectively.

P-Selectin上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验
Crizanlizumab Sel-G-1; SEG-101; SEG101; Sel-G1 批准上市 Selexys Pharmaceuticals Corp Adakveo, Ryverna United States 镰状细胞血症 Novartis Pharmaceuticals Corp 2019-11-15 新型冠状病毒感染, 脑白质病, 骨髓纤维化, 阴茎异常勃起, 镰状细胞血症 详情

P-Selectin临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Inclacumab RO-4905417; RG-1512; LC-1004-002; R-1512; PF-07940370; LC1004-002; DSM ACC2641; DSM-ACC-2641; RO 4905417 临床三期 Genmab A/S, 罗氏 疼痛, 心肌梗塞, 血管移植物阻塞, 镰状细胞血症, 外周动脉疾病 详情

扫一扫关注微信公众号获取ACRO最新资讯

ACROBiosystems百普赛斯生物科技股份有限公司

全国：+86 400-682-2521

北京：010-53681107

上海：021-50850665

海外：+1 800-810-0816

邮箱：（产品订购）order.cn@acrobiosystems.com

邮箱：（技术支持）tech.cn@acrobiosystems.com

邮箱：（廉洁合规）lianjie@acrobiosystems.com

地址：北京经济技术开发区宏达北路8号5号楼4层

新闻订阅

订阅

在线留言

发送
隐私政策 | 法律法规 | 网站地图 | 加入我们
©2017 ACROBiosystems中国 京公网安备 11030102010599号 京ICP备16032159号-1

消息提示

请输入您的联系方式,再点击提交！

确定